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Abstract
We report here on the cloning and functional characterization of human Na-dependent vitamin C transporter 1 (SVCT1).
The human SVCT1 cDNA, obtained from a Caco2 cell cDNA library, encodes a protein of 598 amino acids with 12 putative
transmembrane domains. The SVCT1-specific transcript, 2.4 kb in size, is expressed in kidney, liver, small intestine, thymus
and prostate. When expressed heterologously in HRPE cells, SVCT1 mediates the transport of ascorbate, the reduced form
of vitamin C, in a Na-dependent manner. The transporter is specific for ascorbate with a Kt ofV75 WM. The relationship
between the cDNA-specific uptake rate of ascorbate and Na concentration is sigmoidal with a Na :ascorbate stoichiometry
of 2:1, indicating that the transport process is electrogenic. In Caco2 cells and in normal human intestine, SVCT1 also exists
as a non-functional splice variant with a four amino acid sequence inserted between E-155 and V-156. The splice variant
results from the use of a donor site 12 bp downstream of the normal donor site. ß 1999 Published by Elsevier Science B.V.
All rights reserved.
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Ascorbate (vitamin C), an essential cellular nu-
trient, is involved in a variety of metabolic reactions
and is an important reducing agent in biological sys-
tems [1^3]. While certain animals like the rat and
rabbit are capable of endogenous synthesis of ascor-
bate from glucose, humans depend on the dietary
supply to meet their requirements for this anti-oxi-
dant. Two types of membrane transport activity have
been described for entry of vitamin C into mamma-
lian cells : transport by a high-a⁄nity/low-capacity
active carrier, as well as a low-a⁄nity/high-capacity
facilitative carrier. The high-a⁄nity carrier is a Na-
dependent transport system that accepts only the re-
duced ascorbate as the substrate [4^8]. The low-af-
¢nity carrier is a Na-independent system mediated
by the facilitative glucose transporters (GLUTs)
[9,10]. The substrate for this system is the oxidized,
non-ionic form (dehydroascorbic acid, DHAA) of
vitamin C. Once inside the cell, the DHAA is rapidly
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reduced to ascorbic acid, providing a mechanism for
its concentrative accumulation inside the cell. How-
ever, since the vitamin is predominantly present in its
reduced form under physiological conditions [11] and
also since the GLUTs have a higher a⁄nity for glu-
cose than for DHAA [12], it is highly unlikely that
GLUT-mediated vitamin C transport will su⁄ce the
cellular needs for the vitamin.
Recently, Tsukaguchi et al. [13] have isolated two
ascorbate transporters, Na-dependent vitamin C
transporter (SVCT) 1 and SVCT2, from rat kidney
and rat brain, respectively. Both the transporters me-
diate, when expressed in Xenopus oocytes, Na-de-
pendent electrogenic transport of ascorbate. The two
proteins share an amino acid sequence identity of
65% and show di¡erential tissue distribution. While
SVCT1 is restricted to absorptive tissues (intestine
and kidney) and the liver, SVCT2 is more widely
distributed.
In this paper, we report on the cloning of the
human SVCT1 (hSVCT1) cDNA from a Caco2 cell
(a human intestinal cell line) cDNA library. We have
expressed this cDNA in HRPE cells by the vaccinia
virus expression technique and characterized the
transport function mediated by the cDNA. Similar
to that seen in the rat, the hSVCT1 is expressed in
kidney, intestine and liver as demonstrated by North-
ern analysis and dot-blot analysis of mRNA isolated
from di¡erent tissues of human origin. We also pro-
vide evidence for the presence of a non-functional
splice variant of SVCT1 in Caco2 cells and furnish
the molecular basis for the generation of the splice
variant.
The SuperScript Plasmid system (Gibco BRL) was
used to establish a unidirectional Caco2 cell cDNA
library. The rat SVCT1-speci¢c probe used in the
screening of the cDNA library was obtained by re-
verse transcriptase-polymerase chain reaction (RT-
PCR) using poly(A) RNA isolated from rat kidney.
The primers used were 5P-CGGGAGGTCCAGG-
GTGCAATCATGGT-3P and 5P-AGACAGCCAC-
CAACAAACATCTC-3P, designed based on the
published sequence of rat SVCT1 [13]. A single prod-
uct was obtained with an estimated size of 1061 bp
(from nucleotide 486 to 1546 of rat SVCT1) as pre-
dicted by the primers. The PCR product was cloned
into pGEM-T easy vector (Promega) and sequenced
to con¢rm the identity of the PCR product before
using it as the probe. The probe was labelled with
[K-32P]dCTP by random priming using the ready-to-
go oligolabelling kit (Amersham Pharmacia Biotech)
and used to screen the Caco2 cell cDNA library as
described before [14,15]. A single positive clone was
identi¢ed which was puri¢ed by secondary screening.
The expression of SVCT1 in di¡erent tissues was
determined by Northern analysis. A commercially
available blot with poly(A) RNA isolated from
eight di¡erent human tissues (Clontech, cat# 7760-
1) was probed with hSVCT1 and glyceraldehyde
3-phosphate dehydrogenase (GAPDH) probes under
high stringency conditions. A second blot with RNA
from 43 di¡erent adult human tissues and seven dif-
ferent fetal tissues spotted on a nylon ¢lter (Clon-
tech, cat# 7770-1) was also probed with hSVCT1-
speci¢c probe under high stringency conditions.
The probes were labelled with [K-32P]dCTP by
random priming using the ready-to-go oligolabelling
kit.
Functional expression of the hSVCT1 cDNA was
done using the vaccinia virus expression system in
HRPE cells as described before [15,16]. Subcon£uent
HRPE cells grown on 24 well plates were ¢rst in-
fected with a recombinant (VTF7ÿ3) vaccinia virus
encoding T7 RNA polymerase and then transfected
with the plasmid carrying the full-length cDNA.
Twelve hours post-transfection, uptake measure-
ments were made at 37‡C with [14C]ascorbate. The
transport bu¡er was 25 mM HEPES/Tris (pH 7.5),
containing 140 mM NaCl, 5.4 mM KCl, 1.8 mM
CaCl2, 0.8 mM MgSO4 and 5 mM glucose. In addi-
tion, the transport bu¡er was supplemented with
1 mM dithiothreitol (DTT) to maintain the ascorbate
under reduced state. The uptake was carried out by
incubating the cells with the substrate for 5 min. This
time was chosen because initial time course experi-
ments showed that the uptake was linear up to
C
Fig. 1. hSVCT1 cDNA and the predicted primary amino acid sequence. Putative transmembrane domains are underlined, putative N-
linked glycosylation sites are boxed and putative phosphorylation sites are circled. The point of 12 bp insertion is marked with an ar-
row.
BBAMEM 70868 28-10-99
H. Wang et al. / Biochimica et Biophysica Acta 1461 (1999) 1^92
BBAMEM 70868 28-10-99
H. Wang et al. / Biochimica et Biophysica Acta 1461 (1999) 1^9 3
15 min. Transport was terminated by aspiration of
the medium containing the radiolabelled substrate,
followed by washing two times with 1 ml of ice-
cold transport medium. The cells were then solubi-
lized in 0.5 ml of 1% SDS in 0.1 N NaOH and the
radioactivity associated with the cells was determined
by liquid scintillation spectrometry. Na-dependence
of the transport process was investigated with the use
of a transport medium in which NaCl was isoosmoti-
cally substituted with N-methyl-D-glucamine
(NMDG) chloride. Endogenous transport was deter-
mined in parallel using cells transfected with empty
vector. The transport values measured in cells trans-
fected with empty vector were subtracted from the
corresponding transport values measured in cells
transfected with vector cDNA to obtain the cDNA-
speci¢c uptake.
A single positive clone was isolated by screening
V1U106 colonies of the Caco2 cell cDNA library
with a cDNA insert size of V2.4 kb in size. Se-
quence analysis of the clone indicated that it was a
full-length clone with a putative translation start site
and an open reading frame. Sequence comparison of
the deduced amino acid sequence of the cDNA iso-
lated from the Caco2 cell cDNA library with the
amino acid sequence of rat SVCT1 indicated that
the cDNA isolated from the Caco2 cell cDNA li-
brary is the hSVCT1. The two proteins were highly
homologous and shared an identity of 89% and sim-
ilarity of 92%. However, the hSVCT1 isolated from
the Caco2 cell cDNA library had an additional four
amino acids (VGLH) located, in reference to rat
SVCT1, between amino acids Glu155 and Val156. Ini-
tial attempts to express this cDNA in HRPE cells by
a vaccinia virus-dependent expression system indi-
cated that the hSVCT1 clone with the additional
four amino acid insert was non-functional. We there-
fore deleted the 12 bp sequence encoding the four
amino acids using the Quick-change site-directed mu-
tagenesis kit (Stratagene) and a mutant oligonucleo-
tide primer pair. The mutant oligonucleotide primers
were 5P-CATATTTGGCACCCAAGGATACGGG-
AGGTCCAGGGTGCAATCATG-3P and its reverse
complement, with the desired deletion in the middle.
The PCR was performed using Pfu DNA polymerase
and the hSVCT1 cDNA as the template. The dele-
tion in the resultant product was con¢rmed by se-
quencing and by its ability to mediate Na-depend-
ent transport of ascorbate when expressed in HRPE
cells.
The nucleotide sequence (GenBank accession #
AF170911) and the deduced amino acid sequence
of the functional hSVCT1 are given in Fig. 1. The
cDNA is 2170 bp long with a 1797 bp long open
reading frame (including the termination codon).
The cDNA encodes a protein of 598 amino acids
long with a predicted molecular mass of 65.2 kDa.
Hydropathy analysis using the Kyte-Doolittle algo-
rithm indicates that the protein is highly hydropho-
bic with 12 transmembrane domains. When the
transmembrane topology of hSVCT1 is modeled sim-
ilar to other solute transporters with both the N-ter-
minus and C-terminus directed towards the cytoplas-
mic side, three putative N-glycosylation sites (N-138,
N-144 and N-230) can be identi¢ed in predicted ex-
tracellular domains. Putative recognition sites for
cAMP-dependent phosphorylation (T-557) and pro-
tein kinase C-dependent phosphorylation (T-15, S-
396, S-454, S-540 and S-574) can also be recognized
in predicted intracellular domains.
Northern analysis using a commercially available
multiple tissue RNA blot indicated that the SVCT1-
speci¢c transcript (V2.4 kb in size) is present in liver
and kidney (Fig. 2). Heart, brain, placenta, lung,
skeletal muscle and pancreas were devoid of any de-
tectable SVCT1-speci¢c transcripts. To assess the
general tissue distribution of hSVCT1 transcript in
humans, we probed a commercially available multi-
ple tissue RNA master blot. The master blot con-
Fig. 2. Northern blot analysis of the hSVCT1-speci¢c transcript
in human tissues. The upper panel is the hybridization signal
obtained with the hSVCT1 cDNA probe. The lower panel is
the hybridization signal obtained with the GAPDH cDNA
probe.
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tained poly(A) RNA from 43 di¡erent adult tissues
and seven di¡erent fetal tissues spotted on a nylon
¢lter. The results obtained indicate that, in addition
to kidney and liver, SVCT1 is also expressed abun-
dantly in small intestine, thymus and prostate in
adults (data not shown). Among the fetal tissues
tested, kidney, liver and thymus are positive for
SVCT1-speci¢c transcript.
The functional characterization of the cloned
hSVCT1 was done in HRPE cells using the vaccinia
virus expression system. The time course of ascorbate
transport was studied in cells transfected either with
the original cDNA clone containing the 12 bp inser-
tion or with the cDNA clone in which the 12 bp
sequence was deleted. The cells transfected with
empty vector served as the control. As seen in Fig.
3, cells transfected with the cDNA in which the 12 bp
was deleted showed signi¢cant stimulation of ascor-
bate uptake in comparison to the vector-transfected
cells. At 5 min incubation, the ascorbate uptake
measured in cells transfected with this cDNA was
V7-fold higher than the ascorbate uptake measured
in vector-transfected cells. This stimulation was not
seen in cells transfected with the cDNA containing
the 12 bp insertion. The transport values measured in
these cells were comparable to that measured in vec-
tor-transfected cells, thereby indicating that the 12
bp insertion, which causes an addition of only four
amino acids without altering the sequence of the rest
of the protein, results in a non-functional transport-
er. The hSVCT1-mediated ascorbate uptake was lin-
ear up to 15 min and therefore, we have used a 5 min
incubation for subsequent initial transport rate meas-
urements.
The ionic requirements of the cDNA-induced
transport activity were investigated by substituting
NaCl in the transport bu¡er with di¡erent salts
and assessing the resultant e¡ect on the transport
of [14C]ascorbate in cDNA-transfected cells (Table
1). Substitution of Na in the transport bu¡er with
Li or K ions abolished the transport completely,
Table 1
Ionic dependence of ascorbate uptake in HRPE cells transiently expressing hSVCT1
Inorganic salt Ascorbate uptake (pmol/106 cells/5 min)
pSPORT pSPORT-cDNA cDNA-speci¢c
NaCl 0.19 þ 0.02 (100) 1.01 þ 0.18 (100) 0.82 (100)
Na-gluconate 0.20 þ 0.04 (105) 0.89 þ 0.10 (88) 0.69 (84)
LiCl 0.03 þ 0.01 (16) 0.03 þ 0.01 (3) 0 (0)
KCl 0.03 þ 0.01 (16) 0.03 þ 0.01 (3) 0 (0)
HRPE cells were transfected with either empty vector or hSVCT1 cDNA. Twelve hours post-transfection, the cells were incubated
with 60 nM [14C]ascorbate for 5 min at 37‡C either in the control bu¡er (25 mM HEPES/Tris, pH 7.5, 5.4 mM KCl, 1.8 mM CaCl2,
0.8 mM MgSO4, 5 mM glucose and 140 mM NaCl) or in bu¡ers in which NaCl was replaced with 140 mM of various inorganic
salts. The bu¡er was supplemented with 1 mM DTT to maintain ascorbate under reduced conditions. When the in£uence of replace-
ment of Cl3 with gluconate was studied, KCl and CaCl2 in the bu¡er were also replaced with potassium gluconate and calcium gluco-
nate, respectively. After incubation for 5 min at 37‡C, the cells were washed with the respective bu¡er (ice-cold) and the radioactivity
associated with the cells quantitated. Uptake measured in control cells transfected with empty vector was subtracted to obtain cDNA-
speci¢c uptake. Values in parentheses are percentages of corresponding control uptake. Data represent means þ S.E.M. from three rep-
licate measurements.
Fig. 3. Time course of ascorbate uptake in control cells trans-
fected with pSPORT (a), in cells transfected with the cDNA
isolated from the Caco2 cell cDNA library containing the 12 bp
insertion (F) and in cells transfected with the hSVCT1 cDNA
from which the 12 bp insertion has been deleted (b). Transport
was measured at 37‡C in the presence of Na. The pH of
transport bu¡er was 7.5 and the concentration of [14C]ascorbate
was 60 nM.
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con¢rming that the transport process is obligatorily
dependent on the presence of Na. When the Cl3 in
the transport bu¡er was replaced with gluconate, the
cDNA-induced transport was only minimally af-
fected, suggesting that Cl3 is not obligatory for the
transport process.
The substrate speci¢city of the cDNA-induced
transport activity was investigated by assessing the
ability of various vitamins to compete with
[14C]ascorbate for the transport process (Table 2).
The transport of [14C]ascorbate (35 nM) was inhib-
ited by V90% by unlabelled ascorbate (1 mM). Oth-
Fig. 5. Na activation kinetics of ascorbate transport in HRPE
cells expressing the cloned hSVCT1 cDNA. Transport of ascor-
bate (60 nM) was studied in HRPE cells transfected with either
pSPORT vector (b) or hSVCT1 cDNA (a) in the presence of
increasing concentrations of Na (0^110 mM). The concentra-
tion of Cl3 in the transport medium was maintained at 140
mM. The osmolality of the medium was kept constant by re-
placing Na with appropriate concentrations of NMDG. Inset,
Hill plot of the cDNA-speci¢c transport. The uptake values
measured in cells transfected with empty plasmid were sub-
tracted from values measured in cells transfected with the plas-
mid-cDNA construct to calculate the cDNA-speci¢c transport.
V, uptake rate in pmol/106 cells/5 min; Vm, the maximal uptake
rate calculated from the experimental data using the Hill equa-
tion.
Table 2
Substrate speci¢city of hSVCT1
Substrate [14C]Ascorbate uptake (pmol/106 cells/5 min)
pSPORT pSPORT-cDNA cDNA-speci¢c
Control 0.19 þ 0.01 (100) 1.47 þ 0.02 (100) 1.28 (100)
Ascorbate 0.01 þ 0.01 (12) 0.17 þ 0.02 (12) 0.16 (12)
Pantothenate 0.19 þ 0.01 (101) 1.46 þ 0.01 (99) 1.27 (99)
Biotin 0.19 þ 0.01 (99) 1.41 þ 0.02 (96) 1.22 (96)
Lipoate (reduced) 0.14 þ 0.01 (75) 1.46 þ 0.04 (99) 1.32 (103)
Nicotinic acid 0.17 þ 0.01 (90) 1.45 þ 0.02 (99) 1.28 (100)
Thiamine 0.20 þ 0.01 (105) 1.40 þ 0.04 (96) 1.20 (94)
HRPE cells were transfected with either pSPORT alone or pSPORT-hSVCT1 cDNA. Twelve hours post-transfection, transport of
[14C]ascorbate (60 nM) was measured in these cells with a 5 min incubation at 37‡C in the absence or presence of indicated vitamins
(1 mM). Values in parentheses are percentages of corresponding control uptake. Data represent means þ S.E.M. for 3^6 determina-
tions.
Fig. 4. Saturation kinetics of hSVCT1-mediated ascorbate
transport. HRPE cells were transfected with either vector alone
(b) or with hSVCT1 cDNA (a). Transport of ascorbate was
measured over an ascorbate concentration range of 2.5^200
WM. The concentration of labelled ascorbate was kept constant
at 60 nM. Transport was measured for 5 min at 37‡C in NaCl-
containing bu¡er, pH 7.5. Inset, Eadie-Hofstee plot of cDNA-
speci¢c transport. The transport values measured in cells trans-
fected with empty plasmid were subtracted from values meas-
ured in cells transfected with the plasmid-cDNA construct to
calculate the cDNA-speci¢c transport. V, ascorbate transport in
nmol/106 cells/5 min; S, ascorbate concentration in WM.
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er vitamins tested (pantothenate, biotin, lipoic acid,
nicotinic acid and thiamine) had no e¡ect on
[14C]ascorbate transport, showing that hSVCT1 en-
codes a transporter which is highly speci¢c for ascor-
bate.
Fig. 4 describes the saturation kinetics of ascor-
bate transport in HRPE cells mediated by hSVCT1.
Transport was measured in vector-transfected cells
and in cDNA-transfected cells with varying concen-
trations of ascorbate (2.5^200 WM). The transport in
control cells was subtracted from the transport in
cDNA-transfected cells to determine the cDNA-spe-
ci¢c transport. The hSVCT1-speci¢c ascorbate up-
take was saturable, with a Michaelis-Menten con-
stant of 74 þ 6 WM.
We next studied the kinetics of Na activation of
the transport process. Ascorbate transport was meas-
ured in HRPE cells expressing hSVCT1 in the pres-
ence of varying concentrations of Na (0^100 mM).
The cDNA-speci¢c uptake was determined by sub-
tracting the uptake measured simultaneously in cells
transfected with pSPORT vector. The relationship
between the uptake rate and the Na concentration
was sigmoidal for the cDNA-speci¢c transport proc-
ess (Fig. 5), suggesting the involvement of more than
one Na per ascorbate molecule transported. The
data were ¢t to the Hill equation and the Hill coef-
¢cient, which is the number of Na ions interacting
with the carrier, was calculated. The value for the
Hill coe⁄cient was 1.6 þ 0.1, which was con¢rmed
Fig. 6. (A) Nucleotide sequence of the PCR product ampli¢ed from the genomic DNA. The letters in uppercase denote exonic se-
quences and the letters in lowercase denote intronic sequences. The splice donor sites and the acceptor sites are marked in bold. The
sequence of the 12 nucleotides present in the splice variant is underlined. (B) Diagram indicating the structure and alternative splicing
pattern of hSVCT1 gene.
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from the slope of the Hill plot (Fig. 5, inset). This
indicates that, for every ascorbate molecule trans-
ported, two Na ions are co-transported. Since as-
corbate exists as a monovalent anion at physiological
pH, the Na :ascorbate stoichiometry of 2:1 renders
the transport process electrogenic.
The original clone that we isolated from the Caco2
cell cDNA library is a splice variant with a 12 bp
insertion. To con¢rm that the 12 bp insertion was
not a cloning artifact and also to understand the
molecular basis of the generation of the splice var-
iant, we ampli¢ed this region of the human genome
by PCR using human genomic DNA isolated from
human leukocytes and the PCR primers 5P-ATA-
CGGGAGGTGGGTTTG-3P (sense) and 5P-GCCC-
CAGCGGTTAGACAG-3P (antisense) (Fig. 6A).
The underlined sequence in the sense primer repre-
sents the ¢rst nine nucleotides of the 12 base insert in
the clone isolated from the Caco2 cell cDNA library.
The antisense primer was 245 bases downstream of
the site of the 12 bp insertion. A 578 bp PCR prod-
uct was obtained which was subcloned and se-
quenced. Comparison of the nucleotide sequence of
the PCR product with the nucleotide sequence of the
functional hSVCT1 indicated that the 578 bp PCR
product contained two introns (Fig. 6A). Following
the 12 nucleotides in the beginning of the ¢rst intron
are the nucleotides GTAAGCA. This GT can form a
potential donor site resulting in the generation of the
splice variant with a 12 bp insertion (Fig. 6B). The
resulting splice variant is inactive with respect to
transport function. RT-PCR using poly(A) RNA
isolated from normal human intestine also showed
the presence of this splice variant in normal enter-
ocytes (data not shown). While it may be too prema-
ture to attach any special signi¢cance to the occur-
rence of the splice variant of hSVCT1, recent studies
have suggested that alternative splicing may be a
mechanism of gene regulation hitherto unknown
[17]. The putative protein coded by the splice variant
contains a four amino acid sequence (VGLH) in-
serted between E-155 and V-156 of the functionally
active SVCT1. This region lies in the second extra-
cellular loop between the putative transmembrane
domains 3 and 4. The molecular mechanism by
which this structural alteration results in the loss of
transport activity remains to be determined.
In conclusion, we have isolated a cDNA
(hSVCT1) from a Caco2 cell cDNA library that,
when expressed in HRPE cells, induces Na gra-
dient-dependent uptake of ascorbate. The functional
characteristics of the induced activity are similar to
those of the ascorbate transport activity described in
the intestine. The SVCT1-speci¢c transcript is ex-
pressed in the intestine, liver, kidney, thymus and
prostate. We have also demonstrated the existence
of a non-functional splice variant of SVCT1 in
Caco2 cells and in normal human intestine. The
splice variant results from the use of the donor site
12 bp downstream of the normal donor site, causing
an addition of 12 nucleotides in the resulting mRNA
variant.
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